Evan Vitale

Accounting Professional

  • Evan Vitale
  • Contact Evan Vitale
  • Evan Vitale | Social Stream

Evan Vitale – What’s New In VC News?

February 11, 2016 by Evan Vitale

By Evan Vitale

Well-known sports agent Leigh Steinberg is launching a venture capital initiative. Steinberg Ventures will invest in emerging companies and startups in sports and entertainment.

Steinberg Ventures is a partnership with private equity firm Alpha Strategies, led by founder and President Jay Rodgers. It will leverage relationships and opportunities sourced primarily through the Steinberg Sports & Entertainment agency, led by Steinberg and Chief Operating Officer Chris Cabott.

You can read the rest of the story here: bit.ly/202u228

The Riverside Company (formerly VSS Riverside) has added PRIMA Eye Group to its Independent Doctors of Optometric Care (IDOC) platform. PRIMA provides consulting services and purchasing programs to independent optometrists in the U.S.
Based in Atlanta, PRIMA serves nearly 400 practices representing almost 900 optometrists. PRIMA is a consulting firm and alliance devoted to helping independent optometrists through every stage of their optometric business, providing one-on-one consulting from a team of experts in marketing, human resources and practice financial analysis to help grow practice revenue.

The full story is here: bit.ly/1JlOdGe

A recent Wall Street Journal blog suggests that biotech venture investors are expecting a slowdown this year despite coming off a record 2015 investing season.

The blog, written by Brian Gormley, says “while fourth-quarter venture capital funding slid in most industries amid fears of an economic slowdown, biotechnology investment sprinted ahead.

The question is how long the run can last.

“Total U.S. venture funding reached $72.30 billion in 2015, its highest level since 2000, despite fourth-quarter investment declines in consumer services, information technology, and other markets, according to industry tracker Dow Jones VentureSource. Biotech was an exception, capturing $2.47 billion last quarter, a 25% jump from Q4 of 2014. A record, $8.95 billion pumped into biotech for the year drove total medical investment to a new peak of $16.10 billion. That was 34% above the previous high of $12.04 billion, reached in 2014.”

Read the entire blog post here: on.wsj.com/1RVvEvh

Filed Under: Evan Vitale, Private Equity Tagged With: Evan Vitale, VC, Venture Capital

Recent Posts

  • Evan Vitale – The Rise of AI-Driven Due Diligence in Venture Capital
  • Evan Vitale – Navigating the Nuances: Unraveling the Intricacies of Private Equity Investments
  • Evan Vitale – Lawmakers Consider Tighter Controls on Private Equity in Healthcare After Hospital Cyberattack Fallout
  • Evan Vitale – Navigating the Evolving Landscape: Trends in Private Equity
  • Evan Vitale – Understanding the Dynamics of Real Estate Private Equity: A Comprehensive Overview

Evan's Other Websites

  • Professional Overview

RSS Latest US News

  • Breaking With Trump, Bacon Says He Won’t Follow His Party ‘Off the Cliff’
  • Trump Warns of Consequences for Musk if He Backs Candidates Against Republicans
  • Law Enforcement Officials Struggle to Fulfill Trump Promises Rooted in Conspiracy Theories
  • The Quiet Unraveling of the Man Who Almost Killed Trump
  • Takeaways From Graduation Speeches by Trump, Taraji P. Henson and Others
Tweets by @evanvitale
Twitter LinkedIn Facebook

Copyright © Evan Vitale · 2025